Quality of Life After Treatment for Bladder Cancer: The Bladder Cancer Survivorship Study
Conditions:
Stage 0a Bladder Cancer AJCC v8
Stage 0is Bladder Cancer AJCC v8
Stage I Bladder Cancer AJCC v8
Stage II Bladder Cancer AJCC v8
Stage IIIA Bladder Cancer AJCC v8
Sponsor: Mayo Clinic
trial.available_in:
БГ
Overview
This study evaluates the effect of bladder cancer treatment on quality of life.
Description
PRIMARY OBJECTIVES:
I. To compare general and disease-specific quality of life outcomes at 6, 12, 24, and 36 months after treatment for localized bladder cancer using the PROMIS-29 and the Bladder Cancer Index (BCI) respectively.
II. To identify patient level characteristics that may influence quality of life outcomes after treatment for localized bladder cancer.
OUTLINE: This is an observational study.
Patients complete surveys and also have their medical records reviewed on study.
Who can participate
Inclusion Criteria:
* Have pathologically confirmed, clinically localized, bladder cancer
* Be willing to complete a survey in English before starting definitive treatment (surgery or radiation);
* Able to give consent.
Exclusion Criteria:
* Does not meet inclusion criteria
БГ